Author: Mack, Ethan A.; Kallal, Lara E.; Demers, Delia A.; Biron, Christine A.
Title: Type 1 Interferon Induction of Natural Killer Cell Gamma Interferon Production for Defense during Lymphocytic Choriomeningitis Virus Infection Document date: 2011_8_9
ID: qkwo747o_8
Snippet: Type 1 IFN responsiveness is required for induction of NK cell IFN-⥠expression. Because induction of the biologically active IL-12p70 heterodimer can be accompanied by higher-level IL-12p40 subunit production (8), representative lavage samples from 0, 24, 30, 36, 40, and 48 h following LCMV infection were tested in an ELISA for the subunit. Consistent with our earlier studies (8) , all samples had IL-12p40 levels at or below the limit of detec.....
Document: Type 1 IFN responsiveness is required for induction of NK cell IFN-⥠expression. Because induction of the biologically active IL-12p70 heterodimer can be accompanied by higher-level IL-12p40 subunit production (8), representative lavage samples from 0, 24, 30, 36, 40, and 48 h following LCMV infection were tested in an ELISA for the subunit. Consistent with our earlier studies (8) , all samples had IL-12p40 levels at or below the limit of detection for the assay (data not shown). To determine if biologically relevant IL-12 was induced below detection limits, uninfected and LCMV-infected mice were treated with control antibody or anti-IL-12p40 antibody neutralizing the function of biologically active IL-12p70 (8) . As a positive control for an IL-12induced IFN-⥠response (21, 22) , mice were given lipopolysaccharide (LPS) i.p. at 6 h prior to harvest. In comparison to LCMV infection, LPS treatment induced higher levels of IFN-⥠in lavage fluids ( Fig. 2A) and higher proportions of NK cells expressing IFN-⥠(Fig. 2B) . The enhanced response to LPS was blocked by the anti-IL-12 treatment. In contrast, the IFN-⥠response to LCMV infection was resistant to the anti-IL-12 treatment ( Fig. 2A and B) . Thus, IL-12 is not required for the NK cell IFN-⥠response elicited by the virus.
Search related documents:
Co phrase search for related documents- anti antibody and control antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- anti antibody and detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- anti antibody and early study: 1, 2, 3
- anti antibody and enhanced response: 1, 2, 3, 4, 5, 6, 7
- anti antibody and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- anti antibody control antibody and control antibody: 1, 2, 3, 4
- anti treatment and assay detection: 1, 2, 3
- anti treatment and control antibody: 1, 2, 3, 4, 5, 6
- anti treatment and detection limit: 1
- anti treatment and early study: 1, 2, 3, 4, 5, 6, 7
- anti treatment and enhanced response: 1, 2
- anti treatment and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- assay detection and control antibody: 1, 2
- assay detection and detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- assay detection and early study: 1, 2, 3
- assay detection and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- assay detection limit and detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- assay detection limit and early study: 1
- assay detection limit and high level: 1
Co phrase search for related documents, hyperlinks ordered by date